12618 results for [current-page:query:search]
Refine Your Search
Corporate Partnerships with LLS
The Leukemia & Lymphoma Society is committed to curing cancer, and we need your help. From event sponsors to employee engagement and retail activatio…
Cindy
Our church choir had put on a big Easter program in , lots of practices and multiple performances. After the fact, several, including me, came down wi…
New Series-Research Highlight: Acute Lymphoblastic Leukemia-New Targets, Pathways and Therapies
LLS Community is launching a new series focused on highlighting research in blood cancer. The first in this series focuses on Acute Lymphoblastic Leuk…
X4 Pharmaceuticals Announces Presentation of Positive Data from Ongoing Phase 1b Clinical Trial of Mavorixafor in Waldenström’s Macroglobulinemia at EHA 2021
BOSTON, June , - X4 Pharmaceuticals, Inc. (Nasdaq: XFOR), a leader in the discovery and development of novel therapies targeting diseases resulting f…
Ryvu Therapeutics Presents Positive Phase I Data for RVU120 at the Virtual EHA Congress
Krakow, Poland – June, – Ryvu Therapeutics [WSE:RVU] today announced the online publication of two posters and an oral presentation demonstrating cl…
Constellation Pharmaceuticals Provides an Update from the Ongoing MANIFEST Study of Pelabresib
CAMBRIDGE, Mass., June , (GLOBE NEWSWIRE) -- Constellation Pharmaceuticals, Inc. (Nasdaq: CNST), a biopharmaceutical company using its expertise in …
Myeloproliferative Neoplasms 3D Model
This model contains the following chapters. Click the "Interact in 3D button" to begin.Healthy Bone MarrowNormal Blood Cell ProductionEssential Thromb…
3D Models
Ann
After being in remission from acute myeloid leukemia (AML) for years, things were going well for me. Then a day after my 48th birthday, I was diagnos…
Lauren
At the age of , I was diagnosed with acute myeloid leukemia (AML). I immediately started undergoing treatment which initially consisted of intense ind…
Kristy
On May , , at years old, I started getting dizzy out of nowhere. I thought maybe I needed to eat and sleep better, but it got worse. I went to the ER…
Joey
Joey Renick is a acute lymphoblastic leukemia (ALL) survivor. He was first diagnosed at the age of , then , and again at . Joey has received years of…
Chelsey
While I was recovering from my stem cell transplant, I was at home with my then - daughter full time. She wasn't able to attend preschool due to the p…
Mona
I was years old when I was diagnosed with stage Hodgkin lymphoma (HL). That was in , and I can now proudly say I’ve been for years! But being a -y…
Manuel
Part : A Survivor’s MissionTen years ago, my life was forever changed by three words, “You have cancer.” Those words shocked my adolescence into real…
Highlights from ASCO 2021
The American Society of Clinical Oncology (ASCO) Annual Meeting took place last week. ASCO brings together the cancer community to explore the latest…
34 Patient Groups: Preservation of protections is an important win — but critical work remains
Patients across the country are finally breathing a sigh of relief. For years, they’ve faced uncertainty about the future of the landmark law that’s e…
Exploring New Approaches in AML Treatment
Topics Covered We invite you to learn more about: Emerging therapies for acute myeloid leukemia (AML) Precision medicine for AML Managing …
Special Grants & Mission Initiatives
LLS Research, along with the rest of Mission, announces special RFPs (requests for proposal) on a regular basis to accelerate blood cancer research ar…
The Greater Los Angeles Region Appoints Four Community Leaders to its Board of Trustees
The Greater Los Angeles Region of The Leukemia & Lymphoma Society® (LLS) Appoints Four Community Leaders to its Board of Trustees New Trustees brin…
LLS Expands Series on Side-Effect Management
LLS has expanded its series of fact sheets on managing side effects to include:
Celebrating Survivorship: Lyndi Abote
In March I began feeling off but I didn't know what it was. I thought perhaps it was a loss of relationship that broke me to my core or that fact tha…
Research Highlight: Changing the Landscape of Treatment for Multiple Myeloma (Part 1)
Patients with active MM require therapy; such as chemotherapy, proteasome inhibitors (Bortezomib, Carfilzomib and Ixazomib), immunomodulatory IMiDs (T…